B. RAWSON, N. S. Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 27, n. 2, p. e58-e67, 2020. DOI: 10.15586/jptcp.v27i2.673. Disponível em: https://www.jptcp.com/index.php/jptcp/article/view/673. Acesso em: 1 oct. 2022.